Robotic Biopsies for Lung Cancer Diagnosis

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Recruiting Observational Study
Lung Carcinoma Metastatic Malignant Neoplasm in the Lung
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
40 (estimated)
Sponsor
Mayo Clinic · Other
Who this trial is looking for

This trial is looking for adults who are at moderate to high risk for lung cancer or have suspected metastatic disease. Participants will provide samples of blood, saliva, and archived tissue to help improve cancer diagnosis and treatment plans.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older
  • I am scheduled for a bronchoscopy
  • I have a moderate to high risk of lung cancer
  • I can provide a blood or saliva sample
  • I can provide archived tissue
  • I can understand and follow study requirements
  • I can give informed consent

You may not be able to join if

  • I have a situation that would limit my compliance with study requirements
  • I am currently institutionalized
  • I am pregnant
  • I have had genetic testing with a 40+ multi-gene panel in the last year
  • I have had somatic tissue testing within the last 3 months

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Subject age 18 years and older * Subject is scheduled/was scheduled for a bronchoscopy as part of standard of care * Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease * Ability to p…
Contacts

No contact information available.